QQQ   290.80 (-1.84%)
AAPL   143.16 (-1.90%)
MSFT   242.65 (-2.22%)
META   147.91 (-2.52%)
GOOGL   97.06 (-2.32%)
AMZN   101.00 (-1.21%)
TSLA   169.27 (-4.85%)
NVDA   193.47 (-5.00%)
NIO   12.03 (-5.35%)
BABA   111.78 (-5.58%)
AMD   73.06 (-3.10%)
T   20.14 (+0.95%)
MU   62.09 (-2.79%)
F   12.94 (-2.49%)
CGC   2.87 (-2.05%)
GE   80.89 (-2.81%)
DIS   108.14 (-1.28%)
AMC   5.01 (-9.07%)
PFE   43.49 (-0.69%)
PYPL   80.25 (-1.93%)
NFLX   354.07 (-1.86%)
QQQ   290.80 (-1.84%)
AAPL   143.16 (-1.90%)
MSFT   242.65 (-2.22%)
META   147.91 (-2.52%)
GOOGL   97.06 (-2.32%)
AMZN   101.00 (-1.21%)
TSLA   169.27 (-4.85%)
NVDA   193.47 (-5.00%)
NIO   12.03 (-5.35%)
BABA   111.78 (-5.58%)
AMD   73.06 (-3.10%)
T   20.14 (+0.95%)
MU   62.09 (-2.79%)
F   12.94 (-2.49%)
CGC   2.87 (-2.05%)
GE   80.89 (-2.81%)
DIS   108.14 (-1.28%)
AMC   5.01 (-9.07%)
PFE   43.49 (-0.69%)
PYPL   80.25 (-1.93%)
NFLX   354.07 (-1.86%)
QQQ   290.80 (-1.84%)
AAPL   143.16 (-1.90%)
MSFT   242.65 (-2.22%)
META   147.91 (-2.52%)
GOOGL   97.06 (-2.32%)
AMZN   101.00 (-1.21%)
TSLA   169.27 (-4.85%)
NVDA   193.47 (-5.00%)
NIO   12.03 (-5.35%)
BABA   111.78 (-5.58%)
AMD   73.06 (-3.10%)
T   20.14 (+0.95%)
MU   62.09 (-2.79%)
F   12.94 (-2.49%)
CGC   2.87 (-2.05%)
GE   80.89 (-2.81%)
DIS   108.14 (-1.28%)
AMC   5.01 (-9.07%)
PFE   43.49 (-0.69%)
PYPL   80.25 (-1.93%)
NFLX   354.07 (-1.86%)
QQQ   290.80 (-1.84%)
AAPL   143.16 (-1.90%)
MSFT   242.65 (-2.22%)
META   147.91 (-2.52%)
GOOGL   97.06 (-2.32%)
AMZN   101.00 (-1.21%)
TSLA   169.27 (-4.85%)
NVDA   193.47 (-5.00%)
NIO   12.03 (-5.35%)
BABA   111.78 (-5.58%)
AMD   73.06 (-3.10%)
T   20.14 (+0.95%)
MU   62.09 (-2.79%)
F   12.94 (-2.49%)
CGC   2.87 (-2.05%)
GE   80.89 (-2.81%)
DIS   108.14 (-1.28%)
AMC   5.01 (-9.07%)
PFE   43.49 (-0.69%)
PYPL   80.25 (-1.93%)
NFLX   354.07 (-1.86%)
NYSEAMERICAN:XTNT

Xtant Medical - XTNT Stock Forecast, Price & News

$0.71
+0.03 (+3.65%)
(As of 01/30/2023 03:12 PM ET)
Add
Compare
Today's Range
$0.68
$0.71
50-Day Range
N/A
52-Week Range
$0.43
$0.92
Volume
20,915 shs
Average Volume
26,353 shs
Market Capitalization
$77.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

XTNT stock logo

About Xtant Medical (NYSEAMERICAN:XTNT) Stock

Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoSTX, Certex Spinal Fixation System, Axle Interspinous Fusion System, and Calix. Thecompany was founded in 2006 and is headquartered in Belgrade, MT.

Receive XTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter.

XTNT Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
"We need batteries. Literally everywhere."
Pretty much every technological megatrend today requires batteries. That includes EVs... 5G... AI... charging stations... and smart energy storage systems. Find out why the U.S. just added graphite to a list of super-critical minerals, calling it "essential for America's National Defense."
XTNT Xtant Medical Holdings, Inc.
Xtant Medical Confirms Scott Neils As New CFO
Xtant Medical names Scott Neils as CFO
See More Headlines
Receive XTNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter.

XTNT Company Calendar

Last Earnings
11/03/2022
Today
1/30/2023
Next Earnings (Estimated)
3/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NYSEAMERICAN:XTNT
Employees
116
Year Founded
N/A

Profitability

Net Income
$-4,850,000.00
Pretax Margin
-15.19%

Debt

Sales & Book Value

Annual Sales
$55.26 million
Book Value
$0.36 per share

Miscellaneous

Free Float
105,291,000
Market Cap
$77.15 million
Optionable
Not Optionable
Beta
0.58

Key Executives

  • Sean E. Browne
    President, Chief Executive Officer & Director
  • Mark Schallenberger
    Chief Operating Officer
  • Scott Neils
    Chief Financial Officer
  • Kevin D. Brandt
    Chief Commercial Officer & Senior Vice President
  • Stephen C. Smith
    VP-Regulatory Affairs & Quality Assurance













XTNT Stock - Frequently Asked Questions

Are investors shorting Xtant Medical?

Xtant Medical saw a decline in short interest during the month of December. As of December 30th, there was short interest totaling 313,100 shares, a decline of 35.3% from the December 15th total of 484,300 shares. Based on an average daily volume of 35,700 shares, the short-interest ratio is presently 8.8 days. Approximately 1.3% of the shares of the company are sold short.
View Xtant Medical's Short Interest
.

When is Xtant Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, March 6th 2023.
View our XTNT earnings forecast
.

How were Xtant Medical's earnings last quarter?

Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) released its earnings results on Thursday, November, 3rd. The medical device company reported ($0.03) EPS for the quarter. The medical device company earned $14.46 million during the quarter. Xtant Medical had a negative net margin of 15.11% and a negative trailing twelve-month return on equity of 28.28%.

When did Xtant Medical's stock split?

Xtant Medical's stock reverse split before market open on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

What other stocks do shareholders of Xtant Medical own?
What is Xtant Medical's stock symbol?

Xtant Medical trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "XTNT."

How do I buy shares of Xtant Medical?

Shares of XTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Xtant Medical's stock price today?

One share of XTNT stock can currently be purchased for approximately $0.69.

How much money does Xtant Medical make?

Xtant Medical (NYSEAMERICAN:XTNT) has a market capitalization of $74.98 million and generates $55.26 million in revenue each year. The medical device company earns $-4,850,000.00 in net income (profit) each year or ($0.11) on an earnings per share basis.

How many employees does Xtant Medical have?

The company employs 116 workers across the globe.

How can I contact Xtant Medical?

Xtant Medical's mailing address is 664 Cruiser Ln, BELGRADE, MT 59714-9719, United States. The official website for the company is xtantmedical.com. The medical device company can be reached via phone at (406) 388-0480, via email at investorrelations@xtantmedical.com, or via fax at 406-388-1354.

This page (NYSEAMERICAN:XTNT) was last updated on 1/30/2023 by MarketBeat.com Staff